TECH - bio-techne.com Operating income before deduction of amortization

Graphic logo of bio-techne.com (TECH)

Bio-Techne Corporation (TECH) is implementing environmental standards in reagent production by optimizing waste recycling. EBITDA demonstrates how management is containing costs during a market downturn, while the 356.18 mark shows the current state of the metric. Stable demand for critical proteins and antibodies provides the company with long-term resilience in the medical research sector.

TECH Bio-Techne Inc. Operating profit before deduction of amortization (11/23/2025 - 11/10/2026)

Bio-Techne (TECH) - metric breakdowns and financial figures

- current price and projected stock value:
Price Bio-Techne Inc.|TECH - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Bio-Techne|TECH - Enterprise Value
- balance sheet equity data:
Accounting Value per Share Bio-Techne|TECH - Company Net Assets|Market Value to Book Value bio-techne.com|TECH - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Bio-Techne Corporation|TECH - Long-Term Debt to Capital|Current Liabilities to Capital Bio-Techne Corp|TECH - Company Aggregate Debts|Debt to Book Value Ratio Bio-Techne|TECH - Company Long-Term Debts|Short-Term Debt Volume Bio-Techne|Quick Liquidity Indicator bio-techne.com
- earnings and multiples data:
TECH - Net Profit|Projected Future Earnings Bio-Techne Corporation|TECH - Price to Earnings Ratio|Future Price to Earnings bio-techne.com|TECH - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Bio-Techne|TECH - Operating profit EBITDA|Net earnings per one share for the last twelve months Bio-Techne|TECH - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year bio-techne.com|TECH - Net earnings per share growth this year|Earnings growth forecast for next year Bio-Techne Corporation
Summary company analytics:Bio-Techne Inc. - TECH
Mass-produced product of Bio-Techne Corporation

The stability of Bio-Techne Corporation (TECH) global biomedical equipment supply chains ensures a continuous cash flow, minimizing the impact of external sanctions. This trend is reflected in the EBITDA analytics, which capture the daily volume of operating cash before depreciation and taxes, allowing investors to identify real business growth phases and avoid purchasing assets at local price peaks.

Who Bio-Techne Corporation competes with

Company profit before taxes, interest and amortization ABT (Abbott Corp.)|Thermo Fisher Scientific - Operating profit EBITDA|Operating income before deduction of amortization gehealthcare.com GEHC|MTD: Operating profit EBITDA|Operating profit before deduction of amortization Waters Corp|Operating profit before deduction of amortization BRKR|AZTA: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Varex Imaging (VREX)|Operating profit before deduction of amortization semlerscientific.com SMLR|Operating profit EBITDA BFLY (Butterfly Network)|Mesa Laboratories Inc (MLAB) - Profit before interest, taxes and amortization|Quantum-Si Corp - Operating profit EBITDA|NNOX (Nano-X Imaging Ltd) - Operating profit before amortization|QTRX: Operating profit EBITDA|MASS - Operating income before deduction of amortization|CV (CapsoVision, Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization MaxCyte Inc. (MXCT)|Operating profit EBITDA RPID|Operating profit EBITDA Seer Bio (SEER)|Profit before payment of interest, taxes and amortization Hyperfine, Inc. HYPR|fonar.com - Profit before payment of interest, taxes and amortization|DXR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization MDAI (spectral-ai.com)|VIVS: Operating profit EBITDA|Profit before interest, taxes and amortization Aclarion Corporation (ACON)|Profit before payment of interest, taxes and amortization Akoya Biosciences Inc|THMO - Operating profit before depreciation charges|Operating profit before deduction of amortization TLIS (Talis Biomedical)|Operating profit EBITDA T2 Biosystems Inc. (TTOO)